BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19089939)

  • 1. CABG versus DES PCI in diabetics with multivessel disease: back to the BARI registry.
    Hillegass W
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):59-60. PubMed ID: 19089939
    [No Abstract]   [Full Text] [Related]  

  • 2. PCI versus CABG for multivessel coronary disease in diabetics.
    Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivessel disease in diabetics: does DES level the field?
    Hillegass W
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):881-2. PubMed ID: 19455651
    [No Abstract]   [Full Text] [Related]  

  • 5. Does prior PCI influence the clinical outcome of CABG?
    Taggart DP
    EuroIntervention; 2009 May; 5 Suppl D():D21-4. PubMed ID: 19736065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):22-4. PubMed ID: 19089931
    [No Abstract]   [Full Text] [Related]  

  • 7. The SYNTAX score in practice: an aid for patient selection for complex PCI.
    Feldman T
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):618-9. PubMed ID: 19309708
    [No Abstract]   [Full Text] [Related]  

  • 8. Trifurcation left main coronary artery percutaneous revascularization--pushing catheters and envelopes.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):32-3. PubMed ID: 19089933
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
    Sobel BE
    Coron Artery Dis; 2010 May; 21(3):189-98. PubMed ID: 20308880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stenting the coronaries and bypassing the evidence in patients with multivessel coronary artery disease: time to set the record straight.
    Zingone B
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):362-70. PubMed ID: 17443104
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents.
    Shaw JA; Andrianopoulos N; Duffy S; Walton AS; Clark D; Lew R; Sebastian M; New G; Brennan A; Reid C; Ajani AE;
    Cardiovasc Revasc Med; 2008; 9(4):218-23. PubMed ID: 18928945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stents or drug-eluting conduits for multivessel disease?
    Alfieri O; Maisano F; Benussi S; Toracca L; Castiglioni A
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):359-61. PubMed ID: 17443103
    [No Abstract]   [Full Text] [Related]  

  • 13. Stenting unprotected left main: the outcome is not always favorable.
    Colombo A
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):539-40. PubMed ID: 18307235
    [No Abstract]   [Full Text] [Related]  

  • 14. CABG or PCI: which is better? Bypass or angioplasty with stent? For multivessel disease, some say surgery is the superior treatment.
    Health News; 2006 May; 12(5):8-10. PubMed ID: 16685751
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
    Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
    J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Stick the landing," for optimal ostial placement of stents.
    Morrison DA
    Catheter Cardiovasc Interv; 2009 May; 73(6):769-70. PubMed ID: 19367630
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
    Freeman M; Clark DJ; Andrianopoulos N; Duffy SJ; Lim HS; Brennan A; Charter K; Shaw J; Horrigan M; Ajani AE; Sebastian M; Reid CM; Farouque HM;
    Catheter Cardiovasc Interv; 2009 May; 73(6):763-8. PubMed ID: 19309731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of clinical wisdom in randomised studies, real-world registries and new hypotheses.
    Bernardi G; Morocutti G; Spedicato L; Zanuttini D
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):313-7. PubMed ID: 17443094
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous coronary intervention versus coronary artery bypass surgery in multivessel disease: a current perspective.
    Soran O; Manchanda A; Schueler S
    Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):666-71. PubMed ID: 19307243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.